Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial - PubMed (original) (raw)
. 2000 Dec;21(6 Suppl):349S-355S.
doi: 10.1016/s0197-2456(00)00101-x.
D Reding, W Kopp, A F Subar, N Bhat, N Rothman, N Caporaso, R G Ziegler, C C Johnson, J L Weissfeld, R N Hoover, P Hartge, C Palace, J K Gohagan; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
Affiliations
- PMID: 11189687
- DOI: 10.1016/s0197-2456(00)00101-x
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
R B Hayes et al. Control Clin Trials. 2000 Dec.
Abstract
The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, which is randomizing 74,000 screening arm participants (37,000 men, 37,000 women; ages 55-74) and an equal number of nonscreened controls, is a unique setting for the investigation of the etiology of cancer and other diseases and for the evaluation of potential molecular markers of early disease. At entry, baseline information is collected by questionnaire on dietary intake, tobacco and alcohol use, reproductive history (for women), family history of cancer, use of selected drugs, and other selected risk factors. Blood samples collected at the baseline screening exam are aliquoted to serum, plasma, red blood cell, and buffy coat fractions. At the next two annual screening visits, serum samples are collected. At the third annual reexamination, cryopreserved whole blood is obtained, in addition to serum, plasma, red blood cell, and buffy coat fractions. At the fourth and fifth years, serum, plasma, and buffy coat are collected. All blood samples are shipped to a central repository for long-term storage at -70 degrees C. Dietary questionnaires and buccal cells for DNA analysis are obtained from nonscreened controls. Cancer cases are identified through annual follow-up questionnaires, and all deaths are identified through vital status tracing mechanisms. Procedures are being developed to obtain archival pathologic material for selected cases of cancer and related diseases. Initial investigations are focusing on the etiology of colorectal cancer and on the operative characteristics of tests for the early detection of colorectal and prostate cancer.
Similar articles
- The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
Gohagan JK, Prorok PC, Hayes RB, Kramer BS; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. Gohagan JK, et al. Control Clin Trials. 2000 Dec;21(6 Suppl):251S-272S. doi: 10.1016/s0197-2456(00)00097-0. Control Clin Trials. 2000. PMID: 11189683 - Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. Prorok PC, et al. Control Clin Trials. 2000 Dec;21(6 Suppl):273S-309S. doi: 10.1016/s0197-2456(00)00098-2. Control Clin Trials. 2000. PMID: 11189684 Clinical Trial. - Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Andriole GL. Andriole GL. Recent Results Cancer Res. 2014;202:53-7. doi: 10.1007/978-3-642-45195-9_6. Recent Results Cancer Res. 2014. PMID: 24531777 - The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results.
Gohagan JK, Prorok PC, Greenwald P, Kramer BS. Gohagan JK, et al. Rev Recent Clin Trials. 2015;10(3):173-80. doi: 10.2174/1574887110666150730123004. Rev Recent Clin Trials. 2015. PMID: 26238115 Review. - Data Processing and Analytic Support in the PLCO Cancer Screening Trial.
Mabie J, Riley T, Marcus PM, Black A, Rozjabek H, Yu K, Young M, Austin J, Rathmell J, Williams C, Prorok PC. Mabie J, et al. Rev Recent Clin Trials. 2015;10(3):233-7. doi: 10.2174/1574887110666150730122723. Rev Recent Clin Trials. 2015. PMID: 26238116 Review.
Cited by
- Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer.
Kwak S, Wang C, Usyk M, Wu F, Freedman ND, Huang WY, McCullough ML, Um CY, Shrubsole MJ, Cai Q, Li H, Ahn J, Hayes RB. Kwak S, et al. JAMA Oncol. 2024 Sep 26:e244006. doi: 10.1001/jamaoncol.2024.4006. Online ahead of print. JAMA Oncol. 2024. PMID: 39325441 - Endogenous sex steroid hormones and risk of liver cancer among US men: Results from the Liver Cancer Pooling Project.
Wu Z, Petrick JL, Florio AA, Guillemette C, Beane Freeman LE, Buring JE, Bradwin G, Caron P, Chen Y, Eliassen AH, Engel LS, Freedman ND, Gaziano JM, Giovannuci EL, Hofmann JN, Huang WY, Kirsh VA, Kitahara CM, Koshiol J, Lee IM, Liao LM, Newton CC, Palmer JR, Purdue MP, Rohan TE, Rosenberg L, Sesso HD, Sinha R, Stampfer MJ, Um CY, Van Den Eeden SK, Visvanathan K, Wactawski-Wende J, Zeleniuch-Jacquotte A, Zhang X, Graubard BI, Campbell PT, McGlynn KA. Wu Z, et al. JHEP Rep. 2023 Mar 22;5(7):100742. doi: 10.1016/j.jhepr.2023.100742. eCollection 2023 Jul. JHEP Rep. 2023. PMID: 37425211 Free PMC article. - Helicobacter Species and Hepato-Biliary Tract Malignancies: A Systematic Review and Meta-Analysis.
Gros B, Gómez Pérez A, Pleguezuelo M, Serrano Ruiz FJ, de la Mata M, Rodríguez-Perálvarez M. Gros B, et al. Cancers (Basel). 2023 Jan 18;15(3):595. doi: 10.3390/cancers15030595. Cancers (Basel). 2023. PMID: 36765552 Free PMC article. Review. - GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas.
Machiela MJ, Huang WY, Wong W, Berndt SI, Sampson J, De Almeida J, Abubakar M, Hislop J, Chen KL, Dagnall C, Diaz-Mayoral N, Ferrell M, Furr M, Gonzalez A, Hicks B, Hubbard AK, Hutchinson A, Jiang K, Jones K, Liu J, Loftfield E, Loukissas J, Mabie J, Merkle S, Miller E, Minasian LM, Nordgren E, Park B, Pinsky P, Riley T, Sandoval L, Saxena N, Vogt A, Wang J, Williams C, Wright P, Yeager M, Zhu B, Zhu C, Chanock SJ, Garcia-Closas M, Freedman ND. Machiela MJ, et al. Sci Data. 2023 Jan 12;10(1):25. doi: 10.1038/s41597-022-01921-2. Sci Data. 2023. PMID: 36635305 Free PMC article. - Elevated dietary carbohydrate and glycemic intake associate with an altered oral microbial ecosystem in two large U.S. cohorts.
Monson KR, Peters BA, Usyk M, Um CY, Oberstein PE, McCullough ML, Purdue MP, Freedman ND, Hayes RB, Ahn J. Monson KR, et al. Cancer Res Commun. 2022 Dec;2(12):1558-1568. doi: 10.1158/2767-9764.crc-22-0323. Epub 2022 Dec 5. Cancer Res Commun. 2022. PMID: 36567732 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical